Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease

NCT03840343 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Principal Investigator relocation

Conditions

Diabetic Kidney Disease
Diabetic Nephropathies
Diabetes Mellitus, Type 2
Diabetes Mellitus, Type 1
Chronic Kidney Disease
Diabetic Nephropathy Type 2
Kidney Failure
Kidney Insufficiency

Interventions

BIOLOGICAL: Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose
BIOLOGICAL: Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose

Sponsor

Mayo Clinic

Collaborators

[object Object]